UPDATE 1-Merck to develop biosimilars with Parexel

NEW YORK, Jan 12 (Reuters) - Merck & Co struck an alliance with contract researcher Parexel International Corp to develop copies of biotech medicines, deepening the U.S. drugmaker's investment in so-called biosimilar medicines.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.